The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer
2005

Immunohistochemistry in Breast Cancer Lymph Node Analysis

Sample size: 216 publication Evidence: moderate

Author Information

Author(s): Klevesath M B, Bobrow L G, Pinder S E, Purushotham A D

Primary Institution: Cambridge University Hospitals NHS Foundation Trust

Hypothesis

What is the value of immunohistochemistry in detecting metastatic deposits in sentinel lymph nodes compared to traditional H&E examination?

Conclusion

Immunohistochemistry detects only a small proportion of metastasis in sentinel lymph nodes and may have limited value in histopathological examination.

Supporting Evidence

  • 26% of patients had metastasis identified by H&E.
  • Immunohistochemistry detected additional metastasis in 4% of patients.
  • All metastatic deposits identified by IHC were either micrometastasis or isolated tumor cells.

Takeaway

This study looked at how well a special test called immunohistochemistry can find cancer in lymph nodes compared to a regular test. It found that the special test only finds a little bit more cancer.

Methodology

A retrospective review of 476 sentinel lymph nodes from 216 patients was conducted, comparing immunohistochemistry with H&E staining.

Potential Biases

Potential for human error and false positives in immunohistochemistry readings.

Limitations

The study did not address the value of step sectioning and the prognostic significance of micrometastasis remains controversial.

Participant Demographics

Patients had unifocal invasive breast cancer, with a mean tumor size of 15.1 mm.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602641

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication